IXJ vs. XBI
IXJ (iShares Global Healthcare ETF) and XBI (SPDR S&P Biotech ETF) are both Health & Biotech Equities funds - IXJ tracks the S&P Global Healthcare Sector Index while XBI tracks the S&P Biotechnology Select Industry Index. Both are passively managed. Over the past 10 years, IXJ returned 7.66%/yr vs 8.53%/yr for XBI. A 0.63 correlation means they provide meaningful diversification when combined. IXJ charges 0.46%/yr vs 0.35%/yr for XBI.
Performance
IXJ vs. XBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IXJ achieves a -5.26% return, which is significantly lower than XBI's 6.48% return. Over the past 10 years, IXJ has underperformed XBI with an annualized return of 7.66%, while XBI has yielded a comparatively higher 8.53% annualized return.
IXJ
- 1D
- 0.39%
- 1M
- 0.34%
- YTD
- -5.26%
- 6M
- -4.88%
- 1Y
- 9.30%
- 3Y*
- 4.42%
- 5Y*
- 4.02%
- 10Y*
- 7.66%
XBI
- 1D
- 1.62%
- 1M
- -2.75%
- YTD
- 6.48%
- 6M
- 6.92%
- 1Y
- 58.25%
- 3Y*
- 14.73%
- 5Y*
- 0.59%
- 10Y*
- 8.53%
IXJ vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | -5.26% | 14.99% | 0.55% | 3.62% | -4.94% | 19.60% | 12.74% | 23.23% | 2.83% | 20.44% |
XBI SPDR S&P Biotech ETF | 6.48% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Correlation
The correlation between IXJ and XBI is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.58 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.55 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.59 |
Correlation (All Time) Calculated using the full available price history since Feb 7, 2006 | 0.63 |
The correlation between IXJ and XBI has been stable across timeframes, ranging from 0.55 to 0.63 - a consistent structural relationship.
IXJ vs. XBI - Sectors Allocation Comparison
Sectors
IXJ
XBI
Healthcare
Consumer Defensive
-
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IXJ
XBI
Consumer Defensive
IXJ
XBI
-
Basic Materials
IXJ
-
XBI
Communication Services
IXJ
-
XBI
-
Consumer Cyclical
IXJ
-
XBI
-
Energy
IXJ
-
XBI
-
Financial Services
IXJ
-
XBI
Industrials
IXJ
-
XBI
-
Real Estate
IXJ
-
XBI
-
Technology
IXJ
-
XBI
-
Utilities
IXJ
-
XBI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IXJ vs. XBI — Risk / Return Rank
IXJ
XBI
IXJ vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IXJ | XBI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.64 | 2.30 | -1.66 |
Sortino ratioReturn per unit of downside risk | 1.06 | 3.16 | -2.10 |
Omega ratioGain probability vs. loss probability | 1.12 | 1.38 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | 0.87 | 6.02 | -5.16 |
Martin ratioReturn relative to average drawdown | 2.11 | 18.30 | -16.19 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IXJ | XBI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | 2.30 | -1.66 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | 0.02 | +0.27 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | 0.27 | +0.22 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.36 | +0.06 |
Drawdowns
IXJ vs. XBI - Drawdown Comparison
The maximum IXJ drawdown since its inception was -40.60%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for IXJ and XBI.
Loading charts...
Drawdown Indicators
| IXJ | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.60% | -63.89% | +23.29% |
Max Drawdown (1Y)Largest decline over 1 year | -10.78% | -9.72% | -1.06% |
Max Drawdown (3Y)Largest decline over 3 years | -18.14% | -32.99% | +14.85% |
Max Drawdown (5Y)Largest decline over 5 years | -18.14% | -54.71% | +36.57% |
Max Drawdown (10Y)Largest decline over 10 years | -27.35% | -63.89% | +36.54% |
Current DrawdownCurrent decline from peak | -9.27% | -24.96% | +15.69% |
Average DrawdownAverage peak-to-trough decline | -6.92% | -20.93% | +14.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 3.19% | +1.22% |
Volatility
IXJ vs. XBI - Volatility Comparison
The current volatility for iShares Global Healthcare ETF (IXJ) is 3.75%, while SPDR S&P Biotech ETF (XBI) has a volatility of 9.26%. This indicates that IXJ experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IXJ | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.75% | 9.26% | -5.51% |
Volatility (6M)Calculated over the trailing 6-month period | 10.05% | 20.18% | -10.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.55% | 25.50% | -10.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.21% | 32.18% | -17.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.67% | 32.00% | -16.33% |
IXJ vs. XBI - Expense Ratio Comparison
IXJ has a 0.46% expense ratio, which is higher than XBI's 0.35% expense ratio.
Dividends
IXJ vs. XBI - Dividend Comparison
IXJ's dividend yield for the trailing twelve months is around 1.47%, more than XBI's 0.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | 1.47% | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.46% | 1.73% | 2.85% |
XBI SPDR S&P Biotech ETF | 0.34% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
IXJ and XBI have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (9.26%) compared to IXJ (3.75%). In terms of maximum drawdown, IXJ dropped -40.60% vs XBI's -63.89%.
On 10-year performance, XBI leads with 8.53% vs 7.66% for IXJ. On fees, XBI is cheaper at 0.35% per year. On volatility, IXJ has been the lower-risk option at 3.75%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XBI has performed better with a 8.53% return vs 7.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XBI is cheaper with a 0.35% expense ratio, compared with 0.46% for IXJ.
IXJ has the higher dividend yield at 1.47%, compared with 0.34% for XBI.
IXJ tracks S&P Global Healthcare Sector Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: iShares and State Street. Their fees differ too: 0.46% for IXJ and 0.35% for XBI.
XBI currently has the higher Sharpe Ratio (2.30 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IXJ and XBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer